Mike Narachi is the founder of CODA Biotherapeutics. CODA Biotherapeutics has raised $63M in total funding. Latest round: Series A.
Michael Narachi is the former Chief Executive Officer of CODA Biotherapeutics, a biotechnology company that developed a chemogenetic gene therapy platform. Under his leadership, the company raised a total of $34 million in venture funding, including a Series A round, to advance therapeutic candidates for chronic pain conditions and epilepsy. CODA Biotherapeutics ceased corporate operations in March 2023.
Full founder directory · Investor directory · Company funding database · Fundraising library